Statins in homozygous familial hypercholesterolemia

@article{Marais2002StatinsIH,
  title={Statins in homozygous familial hypercholesterolemia},
  author={A. Marais and D. Blom and J. Firth},
  journal={Current Atherosclerosis Reports},
  year={2002},
  volume={4},
  pages={19-25}
}
Homozygous familial hypercholesterolemia is a rare disorder resulting in severe premature atherosclerosis. Drug therapy was previously viewed as inadequate for control of the dyslipidemia, so portacaval shunting, plasmapheresis, and liver transplantation were undertaken to treat this condition. Despite these drastic measures, additional cholesterol-lowering treatment may still be required. Furthermore, there is a need for pharmacologic control until additional measures can be undertaken. The… Expand
33 Citations
Lipoprotein metabolism in familial hypercholesterolemia
Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.
Current management of severe homozygous hypercholesterolaemias
What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs?
  • R. Santos
  • Medicine
  • Atherosclerosis. Supplements
  • 2014
...
1
2
3
4
...

References

SHOWING 1-10 OF 31 REFERENCES
Treatment of homozygous familial hypercholesterolaemia with probucol.
A host of hypercholesterolaemic homozygotes in South Africa.
Portacaval shunt in patients with familial hypercholesterolemia.
...
1
2
3
4
...